Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole (Q46568522)

23 December 2017

title

Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole (English)

1 reference

23 December 2017

main subject

Fasciola hepatica

object named as

Fasciola hepatica

1 reference

L Halferty

1

1 reference

23 December 2017

G P Brennan

2

1 reference

23 December 2017

R E B Hanna

3

1 reference

23 December 2017

H W Edgar

4

1 reference

23 December 2017

M M Meaney

5

1 reference

23 December 2017

M McConville

6

1 reference

23 December 2017

A Trudgett

7

1 reference

23 December 2017

L Hoey

8

1 reference

23 December 2017

I Fairweather

9

1 reference

23 December 2017

publication date

22 April 2008

1 reference

23 December 2017

published in

Veterinary Parasitology

1 reference

23 December 2017

volume

155

1 reference

23 December 2017

issue

1-2

1 reference

23 December 2017

page(s)

49-58

1 reference

23 December 2017

Fasciola hepatica: scanning electron microscopic observations of juvenile flukes following treatment in vitro with the deacetylated (amine) metabolite of diamphenethide (DAMD)

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Fasciola hepatica: Ultrastructural changes to the tegument of juvenile flukes following incubation in vitro with the deacetylated (amine) metabolite of diamphencthide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Triclabendazole: new skills to unravel an old(ish) enigma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Fasciola hepatica: tegumental changes induced in vitro by the deacetylated (amine) metabolite of diamphenethide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Fasciola hepatica: tegumental surface alterations following treatment in vitro with the deacetylated (amine) metabolite of diamphenethide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Fasciola hepatica: motility response to fasciolicides in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Fasciola hepatica: glycocalyx replacement in the juvenile as a possible mechanism for protection against host immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Fasciola hepatica: an immunofluorescent study of antigenic changes in the tegument during development in the rat and the sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

The kinetics of triclabendazole disposition in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Fascioliasis and other plant-borne trematode zoonoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo drug treatment with clorsulon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulfoxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

The activity of triclabendazole against immature and adult Fasciola hepatica infections in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Anthelmintic efficacy of triclabendazole against Fasciola hepatica in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.04.011

10.1016/J.VETPAR.2008.04.011

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017